The molecular subtyping of breast cancer and its clinical treatment significance
10.3760/cma.j.issn.1008-6706.2018.17.036
- VernacularTitle: 乳腺癌分子分型及其临床治疗意义
- Author:
Dihang LI
1
;
Yunsheng LIANG
Author Information
1. Department of Glandular Surgery, The People's Hospital of Guangxi Guidong, Wuzhou, Guangxi 543001, China
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Molecular subtyping;
Clinic Treatment
- From:
Chinese Journal of Primary Medicine and Pharmacy
2018;25(17):2309-2312
- CountryChina
- Language:Chinese
-
Abstract:
The breast cancer is a usual and serious malignant tumor which threatens the women′s health.Molecular subtyping bases on the molecular level, and provides a new classification method for the breast cancer pathology classification, and plays an important guidance significance for the clinical treatment.At present, the breast cancer molecular subtyping is mainly divided into the following subtypes: the Luminal A type and Luminal B type, HER-2 overexpression and the triple negative breast cancer.Different molecular subtyping has different characteristics in treatment reaction, prognosis and the clinical application situation.
